CSTL Castle Biosciences, Inc. - Common stock
NASDAQ · Health Care · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Jul 30, 2026
$35.56
· of 52w range
· above low
· to high
$17.7252w low
$44.2852w high
Market Cap (MRQ)
$1.08B
P/E (TTM)
-55.6
EPS (TTM)
$-0.64
Revenue (TTM)
$357M
your badges
52W Range
$18–$44
Analyst Rating
STRONG BUY
Price Target
$45
P/E
-55.6
ROE
-4.2%
Net Profit Margin
-5.4%
Your badge strip is empty — pin a metric anywhere on this page.
CSTL Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$35.56
Market Cap (MRQ)
$1.08B
P/E (TTM)
-55.6
EPS (TTM)
$-0.64
Revenue (TTM)
$357M
ROE (TTM)
-4.2%
Debt/Equity (MRQ)
0.0
52W Range
$18–$44
CSTL Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$344M2018-12-31 → 2025-12-31
EPS$-0.832018-12-31 → 2025-12-31
Free Cash Flow$28M2019-12-31 → 2025-12-31
Net margin-5.4%2019-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | CSTL | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | -55.65Y avg ≈-11.5 | ≈-11.5 | · | · | |
| P/S (TTM) | 3.05Y avg ≈4.9 | ≈4.9 | 1.5 | Overvalued | |
| P/B (MRQ) | 2.35Y avg ≈2.0 | ≈2.0 | 1.7 | Undervalued | |
| EV / EBITDA (TTM) | -50.1 | · | · | · | |
| Price / FCF (TTM) | -2218.65Y avg ≈-6.2 | ≈-6.2 | · | · | |
| Price / Cash Flow (TTM) | 25.45Y avg ≈-29.6 | ≈-29.6 | 17.9 | Fair value | |
| EV / Revenue (TTM) | 2.3 | · | · | · | |
| EV / FCF (TTM) | -1693.6 | · | · | · | |
| Price / Tangible Book (MRQ) | 2.85Y avg ≈2.6 | ≈2.6 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | CSTL | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Operating Margin (TTM) | -9.0%5Y avg ≈-27.3% | ≈-27.3% | 2.3% | Weak | |
| EBITDA Margin (TTM) | -4.6%5Y avg ≈-20.6% | ≈-20.6% | 3.9% | Weak | |
| Net Profit Margin (TTM) | -5.4%5Y avg ≈-22.0% | ≈-22.0% | 0.39% | Weak | |
| ROA (TTM) | -3.5%5Y avg ≈-7.0% | ≈-7.0% | -4.7% | In line | |
| ROE (TTM) | -4.2%5Y avg ≈-8.0% | ≈-8.0% | -5.6% | Top tier |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | CSTL | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Debt / Equity (MRQ) | 0.0 | · | 0.1 | Low debt | |
| Current Ratio (MRQ) | 6.05Y avg ≈8.2 | ≈8.2 | 1.7 | Strong liquidity | |
| Quick Ratio (MRQ) | 5.65Y avg ≈6.6 | ≈6.6 | 1.1 | Strong liquidity | |
| Long-Term Debt / Equity (MRQ) | 0.0 | · | 0.1 | Low debt |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | CSTL | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | 3.7%5Y avg ≈42.2% | ≈42.2% | · | · | |
| Revenue CAGR 3Y | 35.9%5Y avg ≈46.7% | ≈46.7% | · | · | |
| Revenue CAGR 5Y | 40.6% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | CSTL | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.65Y avg ≈0.5 | ≈0.5 | 1.2 | Weak | |
| Inventory Turnover | 7.75Y avg ≈8.2 | ≈8.2 | 9.8 | Weak | |
| Receivables Turnover | 7.35Y avg ≈7.0 | ≈7.0 | 7.1 | In line | |
| Revenue / Employee | ≈$343.5K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
34.4%
Next Report
Nov 02, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 3, 2026 | $-0.07 | $-0.41 | 83.1% |
| March 31, 2026 | May 11, 2026 | $-0.49 | $-0.50 | 2.0% |
| Dec. 31, 2025 | $-0.08 | $-0.29 | 72.6% | |
| Sept. 30, 2025 | $-0.02 | $-0.53 | 96.2% | |
| June 30, 2025 | $0.15 | $-0.53 | 128.1% | |
| March 31, 2025 | $-0.20 | $-0.07 | -175.9% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $344M | $332M | $220M | $137M | $94M | $63M | $52M | $23M | |
| Cost of Revenue | $71M | $60M | $45M | $32M | $16M | $10M | $7M | $5M | |
| Gross Profit | · | · | · | · | · | $53M | $45M | $17M | |
| R&D Expense | $52M | $52M | $54M | $45M | $30M | $13M | $7M | $5M | |
| SG&A Expense | $229M | $200M | $180M | $143M | $87M | $48M | $30M | $16M | |
| Operating Expenses | · | · | · | · | · | · | $37M | $21M | |
| Operating Income | $-43M | $9M | $-68M | $-73M | $-40M | $-7M | $7M | $-4M | |
| Interest Expense | · | · | $11.0K | $17.0K | $1.0K | $3M | $5M | $2M | |
| Interest Income | $12M | $13M | $11M | $4M | $68.0K | $373.0K | $312.0K | $24.0K | |
| Other Non-op | $144.0K | $0 | $0 | · | · | $0 | $-3M | $-272.0K | |
| Income Tax | $-5M | $3M | $101.0K | $-2M | $-9M | $84.0K | $72.0K | $9.0K | |
| Net Income | $-24M | $18M | $-57M | $-67M | $-31M | $-10M | $5M | $-6M | |
| EPS (Basic) | $-0.83 | $0.66 | $-2.14 | $-2.58 | $-1.24 | $-0.54 | $0.35 | $-5.33 | |
| EPS (Diluted) | $-0.83 | $0.62 | $-2.14 | $-2.58 | $-1.24 | $-0.54 | $-0.21 | $-5.33 | |
| Shares (Basic) | 28,986,000 | 27,776,000 | 26,802,000 | 26,054,000 | 25,137,000 | 18,929,000 | 8,584,000 | 1,906,000 | |
| Shares (Diluted) | 28,986,000 | 29,255,000 | 26,802,000 | 26,054,000 | 25,137,000 | 18,929,000 | 8,658,000 | 1,906,000 | |
| EBITDA | $-2M | $25M | $-56M | $-62M | $-37M | $-7M | $7M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $117M | $120M | $99M | $123M | $330M | $410M | $99M | $4M | |
| Short-term Investments | $183M | $173M | $144M | · | · | · | · | · | |
| Receivables | $43M | $51M | $38M | $23M | $17M | $13M | $15M | $12M | |
| Inventory | $10M | $8M | $8M | $4M | $2M | $2M | $1M | $882.0K | |
| Prepaid Expense | $8M | $8M | $6M | $6M | $5M | $5M | $2M | $675.0K | |
| Current Assets | $361M | $360M | $296M | $292M | $354M | $430M | $117M | $18M | |
| PP&E (Net) | · | · | · | $14M | $10M | $7M | $2M | $2M | |
| PP&E (Gross) | · | · | · | · | · | $9M | $3M | $2M | |
| Accum. Depreciation | · | · | · | · | · | $2M | $1M | $909.0K | |
| Goodwill | $11M | $11M | $11M | $11M | $0 | · | · | · | |
| Intangibles | $89M | $96M | $107M | $116M | $89M | $0 | $0 | $4.0K | |
| Other Non-current Assets | $4M | $1M | $1M | $1M | $2M | $2M | $135.0K | $214.0K | |
| Total Assets | $579M | $531M | $453M | $447M | $463M | $439M | $120M | $22M | |
| Accounts Payable | $19M | $7M | $10M | $5M | $3M | $2M | $2M | $1M | |
| Short-term Debt | · | · | · | · | · | · | · | $0 | |
| Current Liabilities | $69M | $49M | $48M | $36M | $25M | $21M | $15M | $7M | |
| Capital Leases | $25M | $14M | $14M | $12M | $7M | $0 | · | · | |
| Deferred Tax | $2M | $2M | $206.0K | $428.0K | $635.0K | $0 | · | · | |
| Other Non-current Liabilities | · | · | $25.0K | $90.0K | $124.0K | $1M | · | · | |
| Total Liabilities | $108M | $75M | $62M | $48M | $51M | $24M | $35M | $32M | |
| Long-term Debt | $10M | $10M | $0 | · | · | $0 | $27M | $24M | |
| Total Debt | $10M | $10M | · | · | · | $0 | $25M | · | |
| Paid-in Capital | $695M | $656M | $609M | $560M | $505M | $478M | $137M | $921.0K | |
| Retained Earnings | $-224M | $-200M | $-218M | $-161M | $-94M | $-62M | $-52M | $-57M | |
| AOCI | $267.0K | $230.0K | $136.0K | $-381.0K | $0 | · | · | · | |
| Stockholders' Equity | $471M | $456M | $391M | $399M | $412M | $416M | $85M | $-57M | |
| Liabilities + Equity | $579M | $531M | $453M | $447M | $463M | $439M | $120M | $22M | |
| Shares Outstanding | 29,686,314 | 28,483,195 | 27,410,532 | 26,553,681 | 25,378,520 | 24,812,487 | 17,130,907 | 1,916,224 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $41M | $16M | $12M | $11M | $3M | $472.0K | · | · | |
| Stock-based Comp | $46M | $50M | $51M | $36M | $22M | $8M | $1M | $294.0K | |
| Deferred Tax | $-6M | $1M | $-223.0K | $-2M | $-9M | $0 | $0 | $0 | |
| Amort. of Intangibles | $35M | $11M | $9M | $8M | $2M | $0 | $4.0K | $36.0K | |
| Other Non-cash | $8M | $-21M | $-11M | $-20M | $-4M | · | · | · | |
| Operating Cash Flow | $64M | $65M | $-6M | $-42M | $-19M | $10M | $7M | $-12M | |
| CapEx | $36M | $28M | $14M | $6M | $3M | $5M | $937.0K | $277.0K | |
| Investing Cash Flow | $-60M | $-50M | $-16M | $-167M | $-67M | $-5M | $-937.0K | $-277.0K | |
| Stock Issued | · | · | · | · | $0 | $330M | $66M | · | |
| Net Stock Activity | · | · | · | · | $0 | $330M | · | · | |
| Financing Cash Flow | $-7M | $6M | $-2M | $2M | $5M | $306M | $88M | $16M | |
| Net Change in Cash | $-3M | $21M | $-24M | $-207M | $-80M | $311M | $94M | $3M | |
| Taxes Paid | $2M | $3M | $198.0K | $120.0K | $16.0K | $102.0K | $-150.0K | $160.0K | |
| Free Cash Flow | $28M | $37M | $-19M | $-47M | $-22M | $5M | $6M | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | 84.5% | 85.9% | · | |
| Operating Margin | -12.4% | 2.6% | -30.9% | -53.2% | -42.6% | -10.4% | 14.1% | · | |
| Net Margin | -7.0% | 5.5% | -26.2% | -49.0% | -33.3% | -16.4% | 10.2% | · | |
| EBITDA Margin | -0.59% | 7.4% | -25.3% | -45.5% | -39.0% | -10.4% | 14.1% | · | |
| ROA | -4.3% | 3.7% | -12.8% | -14.8% | -6.9% | -3.7% | 7.4% | · | |
| ROE | -5.2% | 4.1% | -14.8% | -16.6% | -7.6% | -3.5% | 6.3% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.3 | 7.3 | 6.2 | 8.1 | 14.2 | 20.6 | 7.6 | · | |
| Quick Ratio | 5.0 | 7.0 | 2.9 | 4.1 | 13.9 | 20.2 | 7.4 | · | |
| Debt / Equity | 0.0 | 0.0 | · | · | · | 0.0 | 0.3 | · | |
| LT Debt / Equity | 0.0 | 0.0 | · | · | · | 0.0 | 0.2 | · | |
| Interest Coverage | · | · | -6179.7 | -4285.6 | -40079.0 | -2.5 | 1.6 | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.7 | 0.5 | 0.3 | 0.2 | 0.2 | 0.7 | · | |
| Inventory Turnover | 7.7 | 7.5 | 7.5 | 10.7 | 7.5 | 5.6 | 6.9 | · | |
| Receivables Turnover | 7.3 | 7.4 | 7.1 | 6.7 | 6.3 | 4.6 | 3.9 | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $15.86 | $16.00 | $14.27 | $15.03 | $16.22 | $16.75 | $4.97 | · | |
| Revenue / Share | $11.88 | $11.35 | $8.20 | $5.26 | $3.74 | $3.31 | $5.99 | · | |
| Cash Flow / Share | $2.22 | $2.22 | $-0.21 | $-1.60 | $-0.76 | $0.52 | $0.81 | · | |
| Cash / Share | $3.93 | $4.20 | $3.61 | $4.63 | $12.99 | $16.52 | $5.77 | · | |
| Dividend / Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Dividend Paid / Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| EPS (TTM) | $-0.83 | $0.62 | $-2.14 | $-2.58 | $-1.24 | $-0.54 | $-0.21 | · |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 3.7% | 51.1% | 60.4% | 45.6% | 50.2% | · | · | · | |
| Revenue CAGR 3Y | 35.9% | 52.2% | 51.9% | · | · | · | · | · | |
| Revenue CAGR 5Y | 40.6% | · | · | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $344M | $332M | $220M | $137M | $94M | $63M | $52M | · | |
| Net Income TTM | $-24M | $18M | $-57M | $-67M | $-31M | $-10M | $5M | · | |
| Market Cap | $1.15B | $759M | $592M | $625M | $1.09B | $1.67B | $589M | · | |
| Enterprise Value | $865M | $476M | · | · | · | $1.26B | $515M | · | |
| P/E | -46.9 | 43.0 | -10.1 | -9.1 | -34.6 | -124.4 | -163.7 | · | |
| P/S | 3.4 | 2.3 | 2.7 | 4.6 | 11.6 | 26.6 | 11.4 | · | |
| P/B | 2.5 | 1.7 | 1.5 | 1.6 | 2.6 | 4.0 | 6.9 | · | |
| P / Tangible Book | 3.1 | 2.2 | 2.2 | 2.3 | 3.4 | 4.0 | · | · | |
| P / Cash Flow | 17.9 | 11.7 | -105.1 | -15.0 | -57.3 | 168.9 | 83.9 | · | |
| P / FCF | 40.8 | 20.8 | -30.7 | -13.2 | -48.4 | 325.8 | 96.9 | · | |
| EV / EBITDA | -424.4 | 19.3 | · | · | · | -192.0 | 70.3 | · | |
| EV / FCF | 30.5 | 13.0 | · | · | · | 245.7 | 84.7 | · | |
| EV / Revenue | 2.5 | 1.4 | · | · | · | 20.1 | 9.9 | · | |
| Earnings Yield | -2.1% | 2.3% | -9.9% | -11.0% | -2.9% | -0.80% | -0.61% | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $104M | $84M | $87M | $83M | $86M | $88M | $86M | $86M | $87M | $73M | $66M | $61M | $50M | $42M | $38M | $37M | |
| Cost of Revenue | $24M | $21M | $18M | $19M | $18M | $16M | $16M | $16M | $15M | $14M | $12M | $11M | $11M | $10M | $10M | $9M | |
| R&D Expense | $15M | $14M | $14M | $13M | $13M | $13M | $12M | $12M | $14M | $14M | $13M | $13M | $13M | $14M | $11M | $11M | |
| SG&A Expense | $66M | $65M | $57M | $56M | $58M | $59M | $50M | $50M | $51M | $48M | $44M | $45M | $45M | $47M | $38M | $37M | |
| Operating Income | $-3M | $-18M | $-4M | $-7M | $-4M | $-28M | $4M | $5M | $5M | $-5M | $-6M | $-10M | $-21M | $-32M | $-23M | $-22M | |
| Interest Expense | · | · | · | · | $9.0K | $8.0K | · | $192.0K | $216.0K | $12.0K | · | $2.0K | $3.0K | $4.0K | · | $6.0K | |
| Interest Income | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $1M | |
| Other Non-op | $-153.0K | $-439.0K | $96.0K | $48.0K | $0 | $0 | $0 | $0 | · | · | · | · | · | · | · | · | |
| Income Tax | $370.0K | $109.0K | $-382.0K | $115.0K | $-5M | $-423.0K | $-2M | $6M | $-1M | $45.0K | $39.0K | $32.0K | $16.0K | $14.0K | $57.0K | $0 | |
| Net Income | $-2M | $-15M | $-2M | $-501.0K | $5M | $-26M | $10M | $2M | $9M | $-3M | $-3M | $-7M | $-19M | $-29M | $-21M | $-20M | |
| EPS (Basic) | $-0.07 | $-0.49 | $-0.07 | $-0.02 | $0.16 | $-0.90 | $0.35 | $0.08 | $0.32 | $-0.09 | $-0.08 | $-0.26 | $-0.70 | $-1.10 | $-0.78 | $-0.77 | |
| EPS (Diluted) | $-0.07 | $-0.49 | $-0.06 | $-0.02 | $0.15 | $-0.90 | $0.32 | $0.08 | $0.31 | $-0.09 | $-0.08 | $-0.26 | $-0.70 | $-1.10 | $-0.78 | $-0.77 | |
| Shares (Basic) | 30,399,000 | 29,889,000 | · | 29,073,000 | 28,914,000 | 28,609,000 | · | 27,840,000 | 27,646,000 | 27,485,000 | · | 26,834,000 | 26,733,000 | 26,607,000 | · | 26,316,000 | |
| Shares (Diluted) | 30,399,000 | 29,889,000 | · | 29,073,000 | 29,545,000 | 28,609,000 | · | 29,401,000 | 28,738,000 | 27,485,000 | · | 26,834,000 | 26,733,000 | 26,607,000 | · | 26,316,000 | |
| EBITDA | $-3M | $-14M | · | $-7M | $-4M | $2M | · | $5M | $5M | $-2M | · | $-10M | $-21M | $-29M | · | $-22M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $62M | $64M | $117M | $86M | $82M | $90M | $120M | $95M | $86M | $83M | · | $91M | $96M | $115M | · | $134M | |
| Short-term Investments | $205M | $198M | $183M | $202M | $194M | $185M | $173M | · | · | · | · | · | · | · | · | · | |
| Receivables | $48M | $42M | $43M | $49M | $52M | $56M | $51M | $50M | $46M | $43M | · | $37M | $31M | $28M | · | $23M | |
| Inventory | $11M | $10M | $10M | $9M | $8M | $7M | $8M | $7M | $8M | $8M | · | $6M | $6M | $5M | · | $4M | |
| Prepaid Expense | $15M | $14M | $8M | $12M | $12M | $11M | $8M | $8M | $7M | $6M | · | $7M | $6M | $7M | · | $7M | |
| Current Assets | $341M | $329M | $361M | $358M | $349M | $349M | $360M | $345M | $320M | $296M | · | $280M | $269M | $271M | · | $299M | |
| PP&E (Net) | · | · | · | · | · | · | · | · | · | · | · | $22M | $21M | $18M | · | $13M | |
| Goodwill | $11M | $11M | $11M | $11M | $11M | $11M | $11M | $11M | $11M | $11M | · | $11M | $11M | $11M | · | $10M | |
| Intangibles | $84M | $87M | $89M | $91M | $93M | $67M | $96M | $100M | $102M | $104M | · | $109M | $111M | $113M | · | $120M | |
| Other Non-current Assets | $4M | $4M | $4M | $1M | $1M | $1M | $1M | $2M | $3M | $2M | · | $2M | $1M | $792.0K | · | $1M | |
| Total Assets | $561M | $548M | $579M | $563M | $545M | $502M | $531M | $515M | $487M | $459M | · | $436M | $425M | $427M | · | $458M | |
| Accounts Payable | $10M | $15M | $19M | $12M | $13M | $9M | $7M | $7M | $10M | $9M | · | $7M | $7M | $10M | · | $6M | |
| Current Liabilities | $57M | $49M | $69M | $55M | $51M | $37M | $49M | $44M | $39M | $32M | · | $36M | $34M | $30M | · | $32M | |
| Capital Leases | $25M | $25M | $25M | $25M | $25M | $14M | $14M | $15M | $14M | $14M | · | $13M | $12M | $11M | · | $12M | |
| Deferred Tax | $2M | $2M | $2M | $3M | $3M | $837.0K | $2M | $4M | $0 | $206.0K | · | $441.0K | $441.0K | $441.0K | · | $614.0K | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | $16.0K | · | $36.0K | $47.0K | $55.0K | · | $124.0K | |
| Total Liabilities | $91M | $86M | $108M | $96M | $89M | $61M | $75M | $74M | $63M | $56M | · | $50M | $47M | $42M | · | $46M | |
| Long-term Debt | $10M | $10M | $10M | $10M | $10M | $10M | $10M | $10M | $10M | $10M | · | · | · | · | · | · | |
| Total Debt | $10M | $10M | · | $10M | $10M | $10M | · | $10M | $10M | $10M | · | · | · | · | · | · | |
| Paid-in Capital | $711M | $700M | $695M | $689M | $677M | $666M | $656M | $650M | $636M | $623M | · | $602M | $588M | $575M | · | $552M | |
| Retained Earnings | $-241M | $-239M | $-224M | $-222M | $-221M | $-226M | $-200M | $-210M | $-212M | $-221M | · | $-216M | $-209M | $-190M | · | $-140M | |
| AOCI | $-256.0K | $-63.0K | $267.0K | $240.0K | $39.0K | $131.0K | $230.0K | $473.0K | $-172.0K | $-111.0K | · | $-71.0K | $-144.0K | $-136.0K | · | $-189.0K | |
| Stockholders' Equity | $470M | $461M | $471M | $467M | $455M | $440M | $456M | $441M | $424M | $402M | $391M | $386M | $379M | $385M | $399M | $411M | |
| Liabilities + Equity | $561M | $548M | $579M | $563M | $545M | $502M | $531M | $515M | $487M | $459M | · | $436M | $425M | $427M | · | $458M | |
| Shares Outstanding | 30,508,534 | 30,295,965 | 29,686,314 | 29,161,863 | 28,981,151 | 28,844,937 | 28,483,195 | 27,975,808 | 27,711,024 | 27,585,669 | 27,410,532 | 26,890,488 | 26,784,008 | 26,686,201 | 26,553,681 | 26,350,530 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $4M | $4M | $4M | $4M | $3M | $30M | $6M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Stock-based Comp | $12M | $10M | $11M | $12M | $11M | $11M | $11M | $13M | $13M | $13M | $12M | $13M | $13M | $14M | $10M | $9M | |
| Deferred Tax | $-3.0K | $-10.0K | $-907.0K | $116.0K | $-5M | $-770.0K | $-2M | $5M | $-2M | $0 | $-236.0K | $0 | $0 | $13.0K | $-38.0K | $0 | |
| Amort. of Intangibles | $2M | $2M | $2M | $2M | $2M | $28M | $4M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Other Non-cash | · | $-21M | · | · | · | $-20M | · | · | · | $-20M | · | · | · | $-13M | · | · | |
| Operating Cash Flow | $15M | $-22M | $27M | $23M | $21M | $-6M | $24M | $23M | $24M | $-7M | $19M | $5M | $-4M | $-25M | $-6M | $-5M | |
| CapEx | $9M | $12M | $7M | $15M | $9M | $5M | $8M | $6M | $5M | $9M | $4M | $2M | $4M | $3M | $2M | $2M | |
| Investing Cash Flow | $-16M | $-26M | $9M | $-18M | $-28M | $-22M | $6M | $-15M | $-21M | $-20M | $-8M | $-10M | $-15M | $17M | $-4M | $-134M | |
| Financing Cash Flow | $-886.0K | $-5M | $-5M | $-919.0K | $101.0K | $-2M | $-5M | $838.0K | $42.0K | $11M | $-3M | $45.0K | $226.0K | $728.0K | $-750.0K | $388.0K | |
| Net Change in Cash | $-2M | $-53M | $31M | $3M | $-7M | $-30M | $25M | $9M | $3M | $-16M | $8M | $-5M | $-19M | $-8M | $-11M | $-139M | |
| Free Cash Flow | · | $-35M | · | · | · | $-11M | · | · | · | $-16M | · | · | · | $-29M | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -3.0% | -22.0% | · | -8.2% | -4.9% | -31.7% | · | 5.9% | 5.8% | -7.5% | · | -15.7% | -42.2% | -75.0% | · | -58.2% | |
| Net Margin | -2.0% | -17.3% | · | -0.60% | 5.2% | -29.4% | · | 2.6% | 10.2% | -3.5% | · | -11.2% | -37.5% | -69.5% | · | -54.7% | |
| EBITDA Margin | -3.0% | -17.3% | · | -8.2% | -4.9% | 2.1% | · | 5.9% | 5.8% | -2.9% | · | -15.7% | -42.2% | -68.1% | · | -58.2% | |
| ROA | -0.37% | -2.8% | · | -0.09% | 0.88% | -5.4% | · | 0.48% | 1.9% | -0.57% | · | -1.6% | -4.2% | -6.7% | · | -4.5% | |
| ROE | -0.45% | -3.2% | · | -0.11% | 1.0% | -6.1% | · | 0.55% | 2.2% | -0.64% | · | -1.7% | -4.7% | -7.5% | · | -4.9% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.0 | 6.7 | · | 6.5 | 6.9 | 9.4 | · | 7.8 | 8.1 | 9.3 | · | 7.7 | 8.0 | 9.0 | · | 9.4 | |
| Quick Ratio | 5.6 | 6.2 | · | 6.1 | 6.5 | 8.9 | · | 3.3 | 3.3 | 3.9 | · | 3.5 | 3.8 | 4.7 | · | 4.9 | |
| Debt / Equity | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | · | · | · | · | · | |
| LT Debt / Equity | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | -472.3 | -3491.0 | · | 26.5 | 23.2 | -390.8 | · | -4820.0 | -7052.3 | -7880.5 | · | -3589.3 |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 2.5 | 2.4 | · | 2.5 | 2.2 | 2.3 | · | 2.5 | 2.1 | 2.3 | · | 2.4 | 2.3 | 3.0 | · | 2.9 | |
| Receivables Turnover | 2.1 | 1.7 | · | 1.7 | 1.8 | 1.8 | · | 2.0 | 2.3 | 2.1 | · | 2.1 | 1.9 | 1.8 | · | 1.8 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $15.41 | $15.23 | · | $16.02 | $15.71 | $15.26 | · | $15.77 | $15.30 | $14.59 | · | $14.35 | $14.14 | $14.43 | · | $15.61 | |
| Revenue / Share | $3.41 | $2.80 | · | $2.86 | $2.92 | $3.08 | · | $2.92 | $3.03 | $2.65 | · | $2.29 | $1.88 | $1.58 | · | $1.41 | |
| Cash Flow / Share | · | $-0.74 | · | · | · | $-0.21 | · | · | · | $-0.25 | · | · | · | $-0.96 | · | · | |
| Cash / Share | $2.04 | $2.10 | · | $2.93 | $2.84 | $3.11 | · | $3.39 | $3.09 | $3.01 | · | $3.39 | $3.58 | $4.30 | · | $5.09 | |
| EPS (TTM) | $-0.64 | $-0.42 | · | $-0.45 | $-0.35 | $-0.19 | · | $0.22 | $-0.12 | $-1.13 | · | $-2.84 | $-3.35 | $-2.71 | · | $-2.05 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $357M | $340M | · | $344M | $346M | $347M | · | $312M | $288M | $251M | · | $192M | $168M | $152M | · | $124M | |
| Net Income TTM | $-19M | $-13M | · | $-12M | $-9M | $-5M | · | $6M | $-3M | $-31M | · | $-76M | $-89M | $-72M | · | $-53M | |
| Market Cap | $728M | $744M | · | $664M | $592M | $577M | · | $798M | $603M | $611M | · | $454M | $367M | $606M | · | $687M | |
| Enterprise Value | $471M | $492M | · | $387M | $326M | $312M | · | $713M | $528M | $538M | · | · | · | · | · | · | |
| P/E | -37.3 | -58.5 | · | -50.6 | -58.3 | -105.4 | · | 129.6 | -181.4 | -19.6 | · | -5.9 | -4.1 | -8.4 | · | -12.7 | |
| P/S | 2.0 | 2.2 | · | 1.9 | 1.7 | 1.7 | · | 2.6 | 2.1 | 2.4 | · | 2.4 | 2.2 | 4.0 | · | 5.6 | |
| P/B | 1.5 | 1.6 | · | 1.4 | 1.3 | 1.3 | · | 1.8 | 1.4 | 1.5 | · | 1.2 | 1.0 | 1.6 | · | 1.7 | |
| P / Tangible Book | 1.9 | 2.0 | · | 1.8 | 1.7 | 1.6 | · | 2.4 | 1.9 | 2.1 | · | 1.7 | 1.4 | 2.3 | · | 2.4 | |
| P / Cash Flow | · | -33.6 | · | · | · | -95.7 | · | · | · | -89.4 | · | · | · | -23.8 | · | · | |
| EV / Revenue | 1.3 | 1.4 | · | 1.1 | 0.9 | 0.9 | · | 2.3 | 1.8 | 2.1 | · | · | · | · | · | · | |
| Earnings Yield | -2.7% | -1.7% | · | -2.0% | -1.7% | -0.95% | · | 0.77% | -0.55% | -5.1% | · | -16.8% | -24.4% | -11.9% | · | -7.9% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $344M | $332M | $220M | $137M | $94M |
| Operating Margin % | -12.4% | 2.6% | -30.9% | -53.2% | -42.6% |
| Net Income | $-24M | $18M | $-57M | $-67M | $-31M |
| Diluted EPS | $-0.83 | $0.62 | $-2.14 | $-2.58 | $-1.24 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Debt / Equity | 0.0 | 0.0 | · | · | · |
| Current Ratio | 5.3 | 7.3 | 6.2 | 8.1 | 14.2 |
| Quick Ratio | 5.0 | 7.0 | 2.9 | 4.1 | 13.9 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $28M | $37M | $-19M | $-47M | $-22M |
Institutional owners (13F) 187 filers · $721.1M total · As of Sept. 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
187
Value held
$721.1M
New positions
20
Exited positions
30
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 20 (-15 vs prior Q) | 30 (-3 vs prior Q) | 79 (+7 vs prior Q) | 53 (-7 vs prior Q) | -627K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| VANGUARD GROUP INC | $85,573,349 | 2,199,829 | 11.87% | Shares |
| BlackRock, Inc. | $78,513,319 | 3,291,963 | 10.89% | Shares |
| RTW INVESTMENTS, LP | $66,263,290 | 2,778,335 | 9.19% | Shares |
| PRINCIPAL FINANCIAL GROUP INC | $41,180,555 | 1,726,648 | 5.71% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $29,251,953 | 1,226,497 | 4.06% | Shares |
| Allianz Asset Management GmbH | $20,970,303 | 879,258 | 2.91% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $20,052,722 | 840,785 | 2.78% | Shares |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | $19,673,197 | 824,872 | 2.73% | Shares |
| STATE STREET CORP | $19,630,772 | 822,079 | 2.72% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $18,986,390 | 795,912 | 2.63% | Shares |
| MACKENZIE FINANCIAL CORP | $18,925,142 | 793,507 | 2.62% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $18,868,635 | 791,085 | 2.62% | Shares |
| Jefferies Financial Group Inc. | $15,440,275 | 647,391 | 2.14% | Shares |
| Qube Research & Technologies Ltd | $14,054,805 | 589,300 | 1.95% | Shares |
| AIGH Capital Management LLC | $13,000,659 | 545,101 | 1.80% | Shares |
| WASATCH ADVISORS LP | $11,171,134 | 455,036 | 1.55% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $8,853,120 | 371,200 | 1.23% | Shares |
| GOLDMAN SACHS GROUP INC | $8,547,768 | 358,397 | 1.19% | Shares |
| Point72 Asset Management, L.P. | $8,522,010 | 357,317 | 1.18% | Shares |
| KENNEDY CAPITAL MANAGEMENT LLC | $8,308,648 | 348,371 | 1.15% | Shares |
| Connor, Clark & Lunn Investment Management Ltd. | $7,911,689 | 331,727 | 1.10% | Shares |
| MORGAN STANLEY | $7,862,987 | 329,684 | 1.09% | Shares |
| Portolan Capital Management, LLC | $7,842,309 | 328,818 | 1.09% | Shares |
| PANAGORA ASSET MANAGEMENT INC | $7,179,804 | 301,040 | 1.00% | Shares |
| Allspring Global Investments Holdings, LLC | $6,975,410 | 292,470 | 0.97% | Shares |
| NORTHERN TRUST CORP | $6,801,019 | 285,158 | 0.94% | Shares |
| CITADEL ADVISORS LLC | $6,328,669 | 265,353 | 0.88% | Shares |
| KORNITZER CAPITAL MANAGEMENT INC /KS | $6,302,005 | 264,235 | 0.87% | Shares |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $6,107,866 | 256,095 | 0.85% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $6,070,660 | 254,535 | 0.84% | Shares |
| Advisors Capital Management, LLC | $5,681,165 | 238,204 | 0.79% | Shares |
| NEW YORK STATE COMMON RETIREMENT FUND | $5,598,692 | 234,746 | 0.78% | Shares |
| PALISADE CAPITAL MANAGEMENT, LP | $5,531,554 | 231,931 | 0.77% | Shares |
| Nuveen, LLC | $5,526,666 | 231,726 | 0.77% | Shares |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $5,278,911 | 221,338 | 0.73% | Shares |
| Trexquant Investment LP | $4,915,747 | 206,111 | 0.68% | Shares |
| MILLENNIUM MANAGEMENT LLC | $4,898,051 | 205,369 | 0.68% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $4,710,232 | 197,494 | 0.65% | Shares |
| AQR CAPITAL MANAGEMENT LLC | $3,972,623 | 166,567 | 0.55% | Shares |
| FIRST TRUST ADVISORS LP | $3,459,776 | 145,064 | 0.48% | Shares |
| Parkman Healthcare Partners LLC | $3,453,265 | 144,791 | 0.48% | Shares |
| Empowered Funds, LLC | $3,394,761 | 142,338 | 0.47% | Shares |
| D. E. Shaw & Co., Inc. | $2,690,018 | 112,789 | 0.37% | Shares |
| Man Group plc | $2,593,950 | 108,761 | 0.36% | Shares |
| TWO SIGMA INVESTMENTS, LP | $2,393,920 | 100,374 | 0.33% | Shares |
| BANK OF AMERICA CORP /DE/ | $2,355,069 | 98,745 | 0.33% | Shares |
| Bank of New York Mellon Corp | $2,337,724 | 98,018 | 0.32% | Shares |
| FRANKLIN RESOURCES INC | $2,330,932 | 97,733 | 0.32% | Shares |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $2,211,754 | 92,736 | 0.31% | Shares |
| UBS Group AG | $2,131,427 | 89,368 | 0.30% | Shares |
Activists & 5%+ owners 1 position
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Sofinnova HealthQuest Partners, L.P. (“HealthQuest”), HealthQuest Venture Management, L.L.C. (“HealthQuest Management”), Dr. Garheng Kong (“Kong”) ×5 filings | Oct. 9, 2020 | · | Initial filing | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 17 insiders · 6 officers · 12 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Frank Stokes | Chief Financial Officer | Aug. 14, 2026 S | 35,177 | 0 | 6 | $-1,458,878 |
| Kristen M Oelschlager | Chief Operating Officer | Sept. 1, 2026 M | 13,356 | 0 | 15 | $-3,577,426 |
| Tobin W Juvenal | Chief Commercial Officer | Sept. 30, 2026 S | 52,007 | 0 | 19 | $-2,723,752 |
| Derek J Maetzold | Pres. & Chief Exec. Officer | Sept. 21, 2026 M | 9,550 | 0 | 170 | $-10,693,482 |
| Bernhard E. Spiess | Chief Business Officer | Dec. 10, 2021 M | 14,696 | 0 | 0 | $0 |
| Federico A. Monzon | Chief Medical Officer | May 22, 2020 M | 31,459 | 0 | 0 | $0 |
| Rodney Cotton | Director | May 28, 2026 A | 32,998 | 0 | 0 | $0 |
| Kim Caple | Director | May 28, 2026 A | 36,121 | 0 | 0 | $0 |
| Ellen Goldberg | Director | May 28, 2026 A | 40,921 | 0 | 0 | $0 |
| Miles Harrison | Director | May 28, 2026 A | 35,631 | 0 | 0 | $0 |
| Tiffany Olson | Director | May 28, 2026 A | 39,573 | 0 | 0 | $0 |
| Bradley G Cole | Director | May 28, 2026 A | 32,976 | 0 | 2 | $-210,727 |
| Daniel Bradbury | Director | May 28, 2026 A | 22,340 | 0 | 0 | $0 |
| Mara G. Aspinall | Director | May 23, 2024 M | 44,139 | 0 | 0 | $0 |
| KABAKOFF DAVID S | Director | June 17, 2021 S | 503,577 | 0 | 0 | $0 |
| Joseph C. Cook III | Director | March 18, 2021 M | 124,407 | 0 | 0 | $0 |
| Bonnie H Anderson | Director | July 16, 2020 S | 21,723 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 38 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| HAPS · Harbor ETF Trust | 0.52% | 31,765 NS | July 31, 2026 | N-PORT |
| IWC · iShares Trust | 0.23% | 101,652 SH | Sept. 11, 2026 | Daily |
| ROSC · Lattice Strategies Trust | 0.22% | 4,906 NS | July 31, 2026 | N-PORT |
| IHF · iShares Trust | 0.14% | 58,276 SH | Sept. 11, 2026 | Daily |
| ESML · iShares Trust | 0.08% | 70,316 SH | Sept. 11, 2026 | Daily |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0.07% | 15,720 NS | July 31, 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0.07% | 2,172 SH | Oct. 2, 2026 | Daily |
| IBB · iShares Trust | 0.07% | 226,120 SH | Sept. 11, 2026 | Daily |
| NUSC · Nushares ETF Trust | 0.06% | 25,475 NS | July 31, 2026 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.05% | 26,084 SH | Aug. 19, 2026 | Daily |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.05% | 36,652 SH | Oct. 2, 2026 | Daily |
| IWM · iShares Trust | 0.03% | 767,126 SH | Sept. 11, 2026 | Daily |
| RSSL · Global X Funds | 0.03% | 14,302 NS | July 31, 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.02% | 172,326 SH | Aug. 19, 2026 | Daily |
| TEXN · iShares Trust | 0.02% | 97 SH | Sept. 11, 2026 | Daily |
| DFAS · Dimensional ETF Trust | 0.02% | 87,066 NS | July 31, 2026 | N-PORT |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0.01% | 933 SH | Oct. 2, 2026 | Daily |
| FHLC · FIDELITY COVINGTON TRUST | 0.01% | 12,441 NS | July 31, 2026 | N-PORT |
| WSML · iShares Trust | 0.01% | 2,193 SH | Sept. 11, 2026 | Daily |
| VXF · VANGUARD INDEX FUNDS | 0.01% | 347,202 SH | Aug. 19, 2026 | Daily |
| VHT · VANGUARD WORLD FUND | 0.01% | 80,555 SH | Aug. 19, 2026 | Daily |
| DFSV · Dimensional ETF Trust | 0.01% | 24,699 NS | July 31, 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.01% | 1,345 NS | July 31, 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.00% | 71,710 NS | July 31, 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0.00% | 2,610 NS | July 31, 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.00% | 3,672 NS | July 31, 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 7,521 NS | July 31, 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.00% | 12,934 NS | July 31, 2026 | N-PORT |
| ITOT · iShares Trust | 0.00% | 34,931 SH | Sept. 11, 2026 | Daily |
| TILT · FlexShares Trust | 0.00% | 948 NS | July 31, 2026 | N-PORT |
| DFUV · Dimensional ETF Trust | 0.00% | 5,356 NS | July 31, 2026 | N-PORT |
| IWV · iShares Trust | 0.00% | 5,526 SH | Sept. 3, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 852,704 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 2,166 SH | Aug. 19, 2026 | Daily |
| IWN · iShares Trust | · | 281,338 SH | Sept. 11, 2026 | Daily |
| SVAL · iShares Trust | · | 24,820 SH | Sept. 3, 2026 | Daily |
| ISCB · iShares Trust | · | 1,252 SH | Sept. 11, 2026 | Daily |
| ISCV · iShares Trust | · | 5,691 SH | Sept. 11, 2026 | Daily |
CSTL Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 15 analysts
BUY
Median target
$45.00
+26.5%
7 46.7%
Strong Buy
7 46.7%
Buy
1 6.7%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
9 analysts · 2026-09-28Mean target $45.11 +26.9%
Now
Current price $35.56
Low$35.00
Mean$45.11
High$57.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| CSTL | $1.15B | -46.9 | 3.7% | -7.0% | -5.2% | · |
| AMN | $606M | -6.4 | -8.5% | -3.5% | -15.3% | 28.3% |
| PNTG | $975M | 33.5 | 36.3% | 3.1% | 8.4% | · |
| OMDA | $922M | -45.1 | 53.2% | -4.9% | -5.8% | 65.7% |
| INNV | $1.61B | -592.5 | 15.9% | -0.26% | -1.1% | 23.0% |
| OPK | · | -4.2 | -14.9% | -37.2% | -17.6% | 33.9% |
| LMRI | · | · | · | · | · | · |
| FLGT | $816M | -84.7 | 13.8% | -18.8% | -5.4% | 40.6% |
| CVS | $100.87B | 57.1 | 7.8% | 0.44% | 2.4% | · |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Jul 30, 2026